为从源头筑牢低敏根基,品牌严苛甄选全球仅约10%的臻稀A2草饲奶牛作为奶源,这些奶牛遵循自然生长 规律,每年超350天户外放牧,96%以青草为食,享受超2000小时自然日照,更坚持0激素催乳、每日仅两次挤 奶的人道饲养方式。相较于工业饲料圈养的奶牛,这种天然草饲奶源不仅富含天然A2型蛋白,更彻底规避 了大豆蛋白、谷物蛋白等常见过敏源,实现0激素、0抗生素、0农药残留、0催奶剂、0转基因的纯净标准, 用自然之力为敏宝瘦宝构建第一道安全屏障。 全球首创小分子氨基酸乳脂球膜科技,奠定低敏吸收基石 在纯净奶源的基础上,高培爱恩思凭借20年婴幼儿肠道健康与营养蛋白研究的深厚积淀,开创性地将小分 子氨基酸与乳脂球膜(MFGM)相结合,打造出独特的"低敏小分子群"配方体系。其中,5种母乳化小分子氨 基酸的分子量仅为羊乳蛋白的约1/38,能被肠道快速吸收,不仅极大降低致敏风险,更能有效合成黏蛋白,修 复敏宝常见的肠道屏障脆弱("肠漏")问题,从根源缓解牛奶过敏症状。而配方中2.2倍于普通奶粉的 MFGM乳脂球膜,搭配母乳低聚糖(HMOs)组成的双益生元系统,更构建起"调肠补脑"的双效机制—— MFGM助力大脑与神经发育,唾液 ...

针对这一痛点，大会提出"战略养娃"方法论，给出系统性解决方案。不同于传统养育模式的零散探索， 该体系以"以终为始、系统布局"为核心，跳出分数竞争的短期目标，聚焦孩子未来核心竞争力与幸福人 生的长远构建。其核心在于推动父母角色从"管教者"向"家庭首席战略官"转变，通过高维认知与情感能 量的注入，为孩子搭建成长"护城河"；同时以科学方法激发孩子内在动力，助力其从"被动接受"转 向"主动成长"，成长为自驱自洽、能主导人生的未来创造者。这一认知升级，为深陷焦虑的中国家庭提 供清晰行动指南，推动家庭教育从"私域经验"迈向"科学体系"。 江南时报讯 在国家全面推进高质量发展、加快建设人才强国的战略背景下，家庭教育作为人才培育的 根基工程，其改革与升级已成为时代赋予的重要命题。1月9日，"未来人才高质量发展大会——战略养 娃 幸福中国节"在江苏省南京市盛大启幕。这场汇聚学界权威、教育实践者与万千家庭的行业盛会，不 止于理念宣讲，更以系统思维破解当下教育痛点、重塑亲子关系新生态，为中国家庭教育规范化、科学 化发展注入强劲动能。 破局教育迷思：实现从"焦虑内耗"到"战略布局"的认知升级 当前，家庭教育正面临深刻的范式困境：碎片 ...

Group 1 - The domestic bond market in 2026 is experiencing a volatile pattern influenced by both policy expectations and changes in liquidity, with a slight upward shift in the yield center of current bonds [1] - Concerns about government bond supply are central to market dynamics, as the recent national fiscal work conference confirmed the continuation of a more proactive fiscal policy in 2026, raising worries about the pressure of long-term bond supply [1] - A structural differentiation trend in the bond market for 2026 seems to be established, with increased government bond issuance expected in the first quarter due to proactive fiscal policies, while demand is weakened by a lessening "asset shortage" logic and potential fund diversion to the stock market [1] Group 2 - Convertible bonds, which combine characteristics of both bonds and stocks, are identified as a key tool for balancing risk and return in the current market environment [1] - The Minsheng Jianyin Fund's fixed income department director highlighted that the current valuation of the convertible bond market remains high, and the fund maintains a significant position in convertible bonds based on three core reasons: optimism about the long-term trend of the equity market, supportive supply-demand structure for convertible bonds, and greater structural exploration potential compared to pure bonds [1] - The Minsheng Jianyin Xinxiang Bond A fund has effectively captured structural opportunities in the market, ranking first among similar products in both one-year and three-year performance metrics as of the end of Q4 2025 [2]

美素佳儿母公司荷兰皇家菲仕兰，荷兰超70%牧场为美素佳儿自家牧场。乳原料和部分重要营养素(如 ARA/DHA)全自供)。从牧场到餐桌的全产业链严苛的管理和品控，经过荷兰和中国政府的双重检验。 一万余名会员奶农均需接受5年以上农牧业专业教育，严格遵循菲仕兰FOQUS全链条质量管控体系的 200余项准则，涵盖动物福利、饲料安全、环境可持续等多个维度。该体系明确要求每头奶牛每日6小时 户外放牧，奶农需详细记录放牧时间，由第三方机构Qlip进行独立评定，菲仕兰同步开展监管与乳业协 暗访监督，确保标准落地。 随着婴幼儿配方乳粉行业监管趋严与消费需求升级，原料安全与供应链可控性已成为衡量品牌核心竞争 力的关键指标。市场监管总局2025年发布的《关于进一步加强婴幼儿配方乳粉原辅料管理有关事宜的公 告》明确提出，婴配乳粉生产企业应依法依规建立生产质量管理体系，设立原辅料质量安全控制要求， 完善原辅料采购验收管理制度。在此行业背景下，荷兰皇家菲仕兰旗下美素佳儿依托百年乳业积淀，构 建全链路自主生产配料体系，以高于国际标准的品质管控，持续回应新生代父母对奶粉安全的核心关 切，树立行业品质标杆。 作为深耕中国市场的国际乳业品牌，美 ...

Core Viewpoint - The implementation of the new basic medical insurance directory and the first commercial insurance innovative drug directory starting January 1, 2026, will enhance the accessibility and affordability of innovative treatments like Baihe An (Zanidatamab) for patients with HER2-positive biliary tract cancer (BTC) [1][2]. Group 1: Drug Approval and Clinical Value - Zanidatamab is the first and only dual-specific antibody approved in China for targeting HER2 in high-expressing BTC, highlighting its unique clinical value [1][4]. - The drug has shown a 51.6% objective response rate (ORR) in previously treated, unresectable HER2-positive advanced or metastatic BTC patients, with a median overall survival (mOS) of 18.1 months [4]. Group 2: Insurance Coverage and Patient Access - The drug is covered under various "Hui Min Bao" commercial supplementary medical insurance projects across multiple regions, allowing eligible patients to receive significant reimbursement for treatment costs [2]. - The combination of the commercial insurance innovative drug directory and "Hui Min Bao" is expected to significantly improve the accessibility and affordability of this innovative drug for more patients [2]. Group 3: Broader Implications and Future Developments - The company aims to address the unmet medical needs in advanced BTC treatment, which has limited options and poor prognosis, by providing innovative therapies that enhance patient quality of life [4][8]. - Zanidatamab is also being developed for other gastrointestinal tumors, including HER2-positive metastatic gastric and colorectal cancers, indicating its potential for broader applications in oncology [5][6].

近期，北京植物医生化妆品股份有限公司在深交所主板IPO审核状态更新为"已问询"，即将登陆A股市 场，展示了DR PLANT植物医生如何通过三十年的战略定力、科研深耕与格局拓展，构建起穿越产业周 期的强大品牌力。 植物医生品牌公司创立于1994年，多年来深耕"高山植物护肤"这一核心赛道。 这种坚守并非固步自封，而是基于对消费趋势的深刻洞察。通过将中国传统高山植物智慧与现代护肤科 技相结合，植物医生成功打造了"石斛兰""紫灵芝""冬虫夏草"等标志性产品系列，在消费者心中建立 了"天然、安全、有效"的鲜明认知。值得注意的是，即使在2022年至2024年行业充满挑战的时期，公司 仍实现了营收的稳定增长与净利润的持续提升，这种穿越周期的韧性，正是长期专注所带来的必然回 报。 植物医生的"长期"除了体现在时间跨度上，更体现在对核心技术"十年磨一剑"的耐心上。 2014年，植物医生与中国科学院昆明植物研究所签订了长达20年的战略合作协议，双方联合成立的研发 中心，是实实在在的科研攻坚。值得一提的是，经过多年持续投入，团队成功从特有铁皮石斛中提取出 高活性的石斛寡糖成分，并验证了其在促进胶原蛋白生成方面的显著功效。这项"石斛 ...

Core Insights - The meeting held by Shuangyi Pharmaceutical on January 4-5, 2026, focused on summarizing the marketing achievements of 2025 and outlining the strategic direction for 2026, emphasizing the theme "Diligent Learning and Practical Work for Breakthroughs, Unity and Execution for New Heights" [1][2] Group 1: 2025 Achievements - In 2025, Shuangyi Pharmaceutical achieved significant growth, with sales and cash recovery both increasing, with cash recovery up by 56% and sales up by 25% year-on-year [2] - The core product, Compound Cold Granules, saw steady sales growth, and the medical sector made breakthrough progress in market development [1][2] Group 2: 2026 Strategic Direction - Chairman Wang Bo expressed expectations for the marketing team to enhance professional capabilities and broaden development horizons, aiming to position the company among renowned pharmaceutical brands like Beijing Tongrentang and Yunnan Baiyao [2] - Vice President Liang Liyan outlined the 2026 marketing strategy, emphasizing a "Change and Stability" approach, maintaining core structures while adapting marketing goals and strategies to market changes [3] Group 3: Team Engagement and Best Practices - The meeting included presentations from various centers, summarizing 2025 achievements and discussing 2026 marketing plans, with a focus on ensuring effective implementation through interactive discussions [3][4] - An awards ceremony recognized outstanding individuals and teams from 2025, fostering a competitive spirit and encouraging collective effort towards achieving the company's goals [5]

Group 1 - The core viewpoint of the article highlights the shift in public health awareness towards comprehensive nutritional solutions, driven by the "Healthy China 2030" initiative, with the brand Yan Professor leveraging this trend through scientific research and innovative product offerings [1] Group 2 - The product strategy of Yan Professor aligns with consumer demands for perceivable, sustainable, and systematic health improvements, featuring combinations like "Light Burn Coffee + Nutritional Simple Meal" for weight management and "0 Worry Probiotic" for gut health [3] - The brand emphasizes a holistic approach to health, integrating traditional Chinese medicine concepts with modern nutritional science through its original theory of "Balanced Intervention" [5] Group 3 - Yan Professor has established a competitive edge by training over 7,000 certified nutritionists and health managers, providing personalized dietary assessments and product recommendations through a digital platform, resulting in an average user interaction frequency of 23 times per year [7] Group 4 - The brand adopts a long-term strategy, focusing on sustainable practices and avoiding short-term trends, with a commitment to becoming a health system company for families rather than merely selling products [9]

近年来，丹阳农商银行以"变中求进、守正创新"为主线，加快推进数字化转型，有力促进了数字金融协 同发展，为普惠金融服务注入新动力。 该行积极运用科技赋能业务。上线智能财报分析系统，自动分析企业财务数据，有效辅助风险识别与授 信决策，提升流程效率。同时，构建对公数字化营销体系，明确职责分工，形成从数据分析到成效监测 的闭环管理，显著提高营销精准性与执行力。此外，创新推出移动展业平台，实现进件、审批、签约、 放款全流程线上化、无纸化办理。平台已累计服务客户超3.1万户，放款金额突破19亿元，大幅提升了 金融服务可得性与便捷性。 在风险管控方面，银行深化信用信息运用，加强内外部数据整合，通过银政、银企合作引入外部数据， 融合行内业务与管理数据，逐步积累自有数据资产。并基于客户贡献度、黏合度等维度构建客户分层管 理体系，实现对公客户的精细分类与价值挖掘，助力支行精准营销与客户价值提升。 通过一系列数字化转型举措，丹阳农商银行在普惠金融领域取得积极进展。截至目前，各项贷款较2025 年年初增长7.23%，其中普惠领域贷款增幅达8.12%，重点信贷客户数增速位列全省前列。未来，该行 将继续深化数字金融协同，依托大数据推动贷 ...

Core Insights - The meeting aimed to summarize the effectiveness of the financial dispute resolution work in 2025 and plan key tasks for 2026, emphasizing collaboration and consensus among stakeholders [1] Group 1: Project Overview - The "Jinfeng Hexin. Rong e Lou City" project has established a professional and efficient multi-governance financial dispute resolution system through mechanism co-construction, efficiency enhancement, governance deepening, and smooth collaboration [2] - The Taicang Financial Dispute Mediation Center reported on the annual mediation data, highlighting the importance of risk prevention and compliance management for financial institutions [1][2] Group 2: Future Directions - The next steps include consolidating platform functions, enhancing collaborative governance mechanisms, establishing the center as a hub for information sharing and policy coordination, and improving the professionalism and standardization of processes and services [2] - The financial regulatory department will continue to strengthen collaboration with the court in areas such as information sharing, risk prevention, and consumer rights protection to build a more robust financial risk prevention system [2] - The Taicang Court will enhance cooperation with financial regulatory agencies to improve the multi-faceted dispute resolution mechanism and upgrade the mediation center from a "dispute resolution platform" to a "governance hub" [2]